αααααβααΎαPLX β’ NYSEAMERICAN
add
Protalix Biotherapeutics Inc
2.04$
αααααααααα(1.47%)+0.030
2.07$
ααΆααα·αα 16 ααααΆ, 7:56:38 PM ααααβααα -5 · USD · NYSEAMERICAN · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
IL
αα·αααΈαα»α
2.06$
α
αααααααααααα
2.02$ - 2.09$
α
ααααααα½αααααΆαα
α»αααααα
1.32$ - 3.10$
ααΎαβαα»αβααΈααααΆα
164.06Β ααΆα USD
ααα ααα½αααΌαααααα
722.40Β ααΆαα
α’αα»ααΆα P/E
44.18
αα·αααααβααΆαααΆα
-
ααααααΆαααΈααααΆα
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 17.85Β ααΆα | -0.60% |
α
αααΆαααααα·ααααα·ααΆα | 7.40Β ααΆα | 32.24% |
α
αααΌααα»ααα | 2.36Β ααΆα | -27.22% |
ααααΆααα
αααααα»ααα | 13.19 | -26.80% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 2.50Β ααΆα | -42.06% |
α’ααααΆαααααααααΆαααααα·αααααΆα | -5.18% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 29.37Β ααΆα | 7.15% |
ααααααααα»α | 82.26Β ααΆα | 33.63% |
ααΆαααα½ααα»αααααΌαααα»α | 29.36Β ααΆα | 0.79% |
ααΌαβααααα»α | 52.91Β ααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 80.42Β ααΆα | β |
ααααααααααΉαααααα
| 3.12 | β |
ααα
ααααααΎαααααα | 6.63% | β |
ααα
ααααααΎααΎααα»α | 9.16% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 2.36Β ααΆα | -27.22% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | -3.73Β ααΆα | -190.91% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -504.00Β ααΆαα | -102.48% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | 0.00 | 100.00% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -4.25Β ααΆα | -205.94% |
ααα αΌαααΆα
αααααΆααααααα | -6.02Β ααΆα | -671.68% |
α’αααΈ
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
ααΆααααααΎαα‘αΎα
1993
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
213
